García-Cosío Mónica, Santón Almudena, Martín Paloma, Camarasa Natalia, Montalbán Carlos, García Juan F, Bellas Carmen
Department of Pathology, Hospital Ramón y Cajal, Madrid, Spain.
Mod Pathol. 2004 Dec;17(12):1531-8. doi: 10.1038/modpathol.3800227.
Hodgkin's lymphoma can be considered in most cases a B-cell lymphoma due to the presence of potentially functional immunoglobulin (Ig) gene rearrangements in the neoplastic cells. In contrast to lymphocyte-predominant Hodgkin's lymphoma, Hodgkin/Reed-Sternberg (HRS) cells from classical Hodgkin's lymphoma have low frequency of B-cell marker expression and lack Ig light and Ig heavy messenger RNA. Recent studies have shown transcription machinery deficiency in Hodgkin's lymphoma caused by an absence of the transcription factors OCT.1, OCT.2 and/or BOB.1. By using the tissue microarray technique, we have performed an immunohistochemical study of OCT.1, OCT.2 and BOB.1 in 325 classical Hodgkin's lymphoma cases. The results have been correlated with the expression of the B-cell markers CD20, CD79a, B-cell-specific activator protein (BSAP) and MUM.1, the presence of Epstein-Barr virus and the histological subtype. The percentage of CD20 and CD79a positivity was low (18 and 18%, respectively), whereas MUM.1 and BSAP were positive in the majority of cases. Considering the positive cases with independence of the intensity of staining, 62% of them expressed OCT.2, 59% OCT.1 and 37% BOB.1. Nevertheless, when we considered only the strongly positive cases, the results were similar to those previously described by others. No statistical association was found between the transcription factor expression, histological subtype and Epstein-Barr virus presence. To our knowledge, this is the largest series of classical Hodgkin's lymphoma cases in which the expression of transcription factors has been studied. We have found a notorious percentage of cases displaying weak positivity for OCT.2 and BOB.1 factors in HRS cells. We propose that other mechanisms different from the absence of transcription factors OCT.2 and BOB.1 might be involved in the control of Ig transcription and B lineage in classical Hodgkin's lymphoma.
由于肿瘤细胞中存在潜在功能性免疫球蛋白(Ig)基因重排,大多数情况下霍奇金淋巴瘤可被视为B细胞淋巴瘤。与淋巴细胞为主型霍奇金淋巴瘤不同,经典型霍奇金淋巴瘤的霍奇金/里德-斯腾伯格(HRS)细胞B细胞标志物表达频率低,且缺乏Ig轻链和Ig重链信使核糖核酸。最近的研究表明,由于缺乏转录因子OCT.1、OCT.2和/或BOB.1,霍奇金淋巴瘤存在转录机制缺陷。通过使用组织微阵列技术,我们对325例经典型霍奇金淋巴瘤病例进行了OCT.1、OCT.2和BOB.1的免疫组织化学研究。结果与B细胞标志物CD20、CD79a、B细胞特异性激活蛋白(BSAP)和MUM.1的表达、爱泼斯坦-巴尔病毒的存在以及组织学亚型相关。CD20和CD79a阳性率较低(分别为18%和18%),而大多数病例中MUM.1和BSAP呈阳性。考虑到阳性病例与染色强度无关,其中62%表达OCT.2,59%表达OCT.1,37%表达BOB.1。然而,当我们仅考虑强阳性病例时,结果与其他人先前描述的相似。在转录因子表达、组织学亚型和爱泼斯坦-巴尔病毒存在之间未发现统计学关联。据我们所知,这是研究转录因子表达的最大系列经典型霍奇金淋巴瘤病例。我们发现HRS细胞中相当比例的病例对OCT.2和BOB.1因子呈弱阳性。我们提出,经典型霍奇金淋巴瘤中Ig转录和B细胞谱系的控制可能涉及不同于缺乏转录因子OCT.2和BOB.1的其他机制。